These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1550373)

  • 41. Treatment of systemic sclerosis.
    Medsger TA
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):877-86. PubMed ID: 1750801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photochemotherapy in kidney transplantation: preliminary results.
    Baron C; Norol F; Dahmane D; Desvaux D; Chopin D; Weil B; Lang P
    Transplant Proc; 1996 Oct; 28(5):2823. PubMed ID: 8908080
    [No Abstract]   [Full Text] [Related]  

  • 43. [Photochemotherapy in vitro--direct effect on epidermal lectin-binding of psoriatic and normal skin].
    Wollina U; Schaarschmidt H; Knopf B; Hipler C
    Dermatol Monatsschr; 1988; 174(6):312-8. PubMed ID: 3208926
    [No Abstract]   [Full Text] [Related]  

  • 44. Scleroderma: therapeutic options.
    Connolly SM
    Cutis; 1984 Sep; 34(3):274-6. PubMed ID: 6386354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
    Høyer H; Hvid-Jacobsen K; Weismann K
    Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia].
    Daróczy J; Gyöngyvér S
    Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y; Kohriyama K; Matsui T
    J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracorporeal photochemotherapy in progressive systemic sclerosis.
    Di Spaltro FX; Cottrill C; Cahill C; Degnan E; Mulford GJ; Scarborough D; Franks AJ; Klainer AS; Bisaccia E
    Int J Dermatol; 1993 Jun; 32(6):417-21. PubMed ID: 8320022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological alterations during photopheresis and D-penicillamine treatment of systemic sclerosis.
    Rietschel RL; Cooper ES
    Ann N Y Acad Sci; 1991 Dec; 636():400-2. PubMed ID: 1793227
    [No Abstract]   [Full Text] [Related]  

  • 50. [Photochemotherapy of neurodermatitis].
    Gschnait F; Hönigsmann H; Konrad K; Fritsch P; Wolff K
    Z Hautkr; 1977 Dec; 52(24):1219-24. PubMed ID: 602339
    [No Abstract]   [Full Text] [Related]  

  • 51. Progressive systemic sclerosis. Diagnosis at the age of 4 years.
    Velayos EE; Cohen BS
    Am J Dis Child; 1972 Jan; 123(1):57-60. PubMed ID: 5010554
    [No Abstract]   [Full Text] [Related]  

  • 52. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.
    Kahl LE; Medsger TA; Klein I
    J Rheumatol; 1985 Oct; 12(5):990-1. PubMed ID: 4087275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis.
    Tewari A; Garibaldinos T; Lai-Cheong J; Groves R; Sarkany R; Branislav Novakovic L
    Photodermatol Photoimmunol Photomed; 2011 Apr; 27(2):113-4. PubMed ID: 21392116
    [No Abstract]   [Full Text] [Related]  

  • 55. [Marked proteinuria in the course of penicillamine treatment of progressive systemic sclerosis].
    Filipecki S; Dabrowska B; Szczepański A; Glyda J
    Pol Tyg Lek; 1971 Nov; 26(46):1780-1. PubMed ID: 5131995
    [No Abstract]   [Full Text] [Related]  

  • 56. Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    Strand V
    Arthritis Rheum; 2002 Nov; 46(11):2836-7. PubMed ID: 12428222
    [No Abstract]   [Full Text] [Related]  

  • 57. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
    Shapiro M; Jimenez S; Werth VP
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA; Sigal SH
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc and zinc-dependent enzymes in penicillamine-treated patients with generalized scleroderma.
    Jepsen LV; Eggert J
    Acta Derm Venereol; 1984; 64(5):424-7. PubMed ID: 6208723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.